NCT02429687 TC or BEP in Treating Patients With Malignant Ovarian Germ Cell Tumors Status RECRUITING Phase PHASE3
NCT02429037 P53 Gene Combined With Radio- and Chemo-therapy in Treatment of Unresectable Locally Advanced Head and Neck Cancer Status UNKNOWN Phase PHASE2
NCT02422563 NeoAdjuvant Chemotherapy Followed by Radical Hysterectomy (OP) Versus Primary Chemo-RADiation in Cervical Cancer FIGO Stage IB2 and IIB Status NOT_YET_RECRUITING Phase PHASE3
NCT02422498 Homologous Recombination Repair Status as a Biomarker of Response in Locally Recurrent/Metastatic Triple Negative Breast Cancer Patients Treated With Concurrent Cisplatin and Radiation Therapy Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT02421640 Phase II Trial of TIL Following CCRT in Patients With Locoregionally Advanced NPC Status UNKNOWN Phase PHASE2
NCT02412670 Chemotherapy Before Surgery in Treating Patients With High Grade Upper Urinary Tract Cancer Status COMPLETED Phase PHASE2
NCT02409355 A Study of Atezolizumab Compared With Gemcitabine Plus (+) Cisplatin or Carboplatin for PD-L1-Selected Participants With Stage IV Squamous Non-Small Cell Lung Cancer (NSCLC) (IMpower111) Status TERMINATED Phase PHASE3
NCT02409342 A Study of Atezolizumab (MPDL3280A) Compared With a Platinum Agent (Cisplatin or Carboplatin) + (Pemetrexed or Gemcitabine) in Participants With Stage IV Non-Squamous or Squamous Non-Small Cell Lung Cancer (NSCLC) [IMpower110] Status COMPLETED Phase PHASE3
NCT02407912 Cisplatin for Malignant Pleural Effusion in Patients With Non-small-cell Lung Cancer Status UNKNOWN Phase NA
NCT02403531 Induction Chemotherapy Followed by Chemoradiotherapy in Esophageal Cancer Status COMPLETED Phase PHASE2
NCT02402920 Pembrolizumab and Concurrent Chemoradiotherapy or Radiation Therapy in Treating Patients With Small Cell Lung Cancer Status COMPLETED Phase PHASE1
NCT02397486 The Impact of Pentoxifylline and Vitamin E on Radiotherapy-induced Toxicity in Head & Neck Cancer Patients Status COMPLETED Phase PHASE2
NCT02394652 The Potential for Metformin to Improve Tumor Oxygenation in Locally Advanced Cervix Cancer: A Phase II Randomized Trial Status COMPLETED Phase PHASE2
NCT02393794 Cisplatin Plus Romidepsin & Nivolumab in Locally Recurrent or Metastatic Triple Negative Breast Cancer (TNBC) Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT02393248 Open-Label, Dose-Escalation Study of Pemigatinib in Subjects With Advanced Malignancies - (FIGHT-101) Status TERMINATED Phase PHASE1/PHASE2
NCT02392637 Gemcitabine Hydrochloride, Cisplatin, and Nab-Paclitaxel in Treating Patients With Advanced or Metastatic Biliary Cancers Status COMPLETED Phase PHASE2
NCT02382068 Dexamethasone in Preventing Hearing Loss in Patients Receiving Cisplatin Status WITHDRAWN Phase NA
NCT02381535 Onalespib in Treating Patients With Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck Receiving Radiation Therapy and Cisplatin Status COMPLETED Phase PHASE1
NCT02375880 Study of DKN-01 and Gemcitabine/Cisplatin in Patients With Carcinoma to Primary to the Intra- or Extra-Hepatic Biliary System or Gallbladder Status COMPLETED Phase PHASE1